Colgate-Palmolive Co (CHIX:CPAd)
€ 68.72 (0%) Market Cap: 65.49 Bil Enterprise Value: 71.62 Bil PE Ratio: 36.27 PB Ratio: 514.97 GF Score: 84/100

Q3 2025 Colgate-Palmolive Co Earnings Call Transcript

Oct 31, 2025 / 12:30PM GMT
Release Date Price: €69.48

Key Points

Positve
  • Colgate-Palmolive Co (CL) is executing its 2030 strategy to accelerate growth, focusing on innovation, omnichannel demand generation, and AI-driven efficiency.
  • The company maintains strong market shares in growing categories and has a diverse global footprint, with nearly 50% exposure to faster-growing emerging markets.
  • Colgate-Palmolive Co (CL) continues to generate strong cash flow, enabling investments in business growth and shareholder returns.
  • The company is leveraging AI and predictive analytics to enhance supply chain efficiency, improve service levels, and drive personalization at scale.
  • Despite a challenging environment, Colgate-Palmolive Co (CL) is committed to delivering organic sales growth, net sales growth, and dollar-based EPS growth.
Negative
  • Colgate-Palmolive Co (CL) faces a volatile operating environment with consumer uncertainty, tariffs, and high cost inflation impacting sales and profit growth.
  • The company experienced a decline in oral care sales in Latin America due to trade inventory replacement and formula changes, impacting gross margins.
  • Colgate-Palmolive Co (CL) is dealing with sluggish category growth in developed markets, with volumes remaining flat despite lower pricing.
  • The company is facing challenges in the Asia Pacific region, particularly in China, where competitive pressures and a shift to e-commerce are impacting performance.
  • Colgate-Palmolive Co (CL) is experiencing increased promotional activity and couponing in the US market, which could pressure margins.
Operator

Good morning. Welcome to today's Colgate Palmolive 3rd quarter 2025 earnings conference call.

This call is being recorded and is being simulcast live at www. Colgate Palmolive.com. Now for opening remarks, I'd like to turn this call over to Chief Investor Relations Officer and executive Vice President MNA John Fouche.

John Faucher
Colgate-Palmolive Co - Chief Investor Relations Officer and Executive Vice President, M&A

Thanks.

Good morning and welcome to our 3rd quarter 2025 earnings conference call.

Today's conference call will include forward-looking statements.

Actual results could differ materially from these statements. Please refer to our third quarter, 2025 earnings press release and related prepared materials and our most recent filings with the SEC, including our 2024 annual report on Form 10K and subsequent SEC filings, all available on Colgatealma's website for discussion of the factors that could cause actual results to differ materially from these statements.

Our remarks will also include a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot